Leinco Technologies manufactures a comprehensive portfolio of high-purity antibodies and recombinant proteins targeting seasonal and respiratory pathogens. The catalog supports the development of rapid diagnostics, vaccines, and therapeutics for respiratory viruses including Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus, Human Metapneumovirus (HMPV), and Enterovirus D68. These reagents are produced in our Missouri facility under ISO 9001:2015 and ISO 13485:2016 quality standards to ensure lot-to-lot consistency for sensitive applications.
Name
Applications
Prod No.
Clone
Availability

